US Endoscopy

US Endoscopy, established in 1991, functions as a specialized division of STERIS plc following its 2012 acquisition. The company operates within the medical devices and equipment manufacturing sector, focusing on the design and production of innovative solutions for gastrointestinal endoscopy and urology markets. By leveraging the global infrastructure of STERIS, US Endoscopy maintains a strong market position, delivering high-quality procedural products that address critical clinical challenges faced by healthcare professionals worldwide.

The company’s product portfolio is extensive, encompassing specialized categories such as bleed management, CO2 insufflation systems, endoscope care, and tissue management devices. US Endoscopy prioritizes collaborative innovation, working directly with luminary physicians and nurses to ensure that every device meets urgent clinical requirements. Meet US Endoscopy's team to understand the expertise driving their product development lifecycle. Their commitment to solution-oriented design ensures that healthcare providers have access to advanced tools for complex procedures, including ERCP, enteroscopy, and laparoscopy, thereby improving patient outcomes across diverse medical settings.

With a workforce of 500-1,000 employees, US Endoscopy maintains a robust operational footprint from its headquarters in Mentor, Ohio. The company generates annual revenue of $85.8M, reflecting its significant impact on the medical device industry. By focusing on high-precision manufacturing and rigorous quality standards, the firm continues to serve both domestic and international markets effectively. Its strategic emphasis on research and development allows it to remain at the forefront of endoscopic technology, consistently delivering reliable, high-performance instruments that support the evolving needs of modern clinical environments.